Across TCGA pan-cancer cohorts, NCCRP1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated NCCRP1 data layer compared with 25 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher NCCRP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NCCRP1 expression acts as an unfavorable survival marker.

HNSC, SCLC, and LGG are the cancer types where NCCRP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.511	0.751	<.001	44	view →
SCLC	DFS	Median	All	0.178	0.631	.005	18	view →
LGG	DFS	Median	All	0.164	0.828	<.001	4	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: NCCRP1 tumor-vs-normal RNA expression · all NCCRP1 data types